We recently have evaluated the Reagin Screen Test (RST; Fisher Diagnostics, Orangeburg, N.Y.) using over 1,000 clinically defined patients (1). Only a few plasma specimens from normal individuals were included in that study. In the present investigation, the reactivity of plasma tested by the RST was compared to the reactivity of serum tested by the VDRL and RST procedures. The aim of this study was to provide data on the reliability of plasma samples for use with the RST. 
. No comparison of VDRL results on serum specimens versus results of a test which uses plasma, using a defined population, has been published.
We recently have evaluated the Reagin Screen Test (RST; Fisher Diagnostics, Orangeburg, N.Y.) using over 1,000 clinically defined patients (1) . Only a few plasma specimens from normal individuals were included in that study. In the present investigation, the reactivity of plasma tested by the RST was compared to the reactivity of serum tested by the VDRL and RST procedures. The aim of this study was 40C) had no effect on the appearance of this atypical reaction. Separation of plasma from the erythrocyte layer before storage also had no effect.
We also examined the effects of storage on reactive samples for up to 72 h after collection. Plasma samples from 12 patients whose serum Plasma specimens tested by the RST demonstrated a sensitivity equal to that of serum samples tested by the RST or VDRL tests. This sensitivity was evident in all groups of syphilis patients. A previous evaluation indicated that the RST was slightly less sensitive than the VDRL, especially when samples were obtained from patients who had been treated for syphilis (1) . Although the number of samples tested in the present study was small, the results obtained suggest that the RST antigen is equal to the VDRL antigen in sensitivity and specificity.
The results of this study suggest that plasma specimens that are processed and tested promptly by the RST yield results equal to those from serum tested by the RST and VDRL tests. However, laboratories that use plasma samples for screening should be warned that these samples cannot be sent to a reference lab for quantitative VDRL testing or confirmation by the Fluorescent Treponemal Antibody Absorption test. Since heating of samples is mandatory for the performance of these latter tests, only serum samples should be tested.
